Clinical lipid control success rate before and after percutaneous coronary intervention in iran; a single center study
- PMID: 24349743
- PMCID: PMC3840832
- DOI: 10.5812/ircmj.3370
Clinical lipid control success rate before and after percutaneous coronary intervention in iran; a single center study
Abstract
Background: High cholesterol levels have long been considered an independent risk factor for cardiovascular disease (CVD).
Objective: Controlling risk factors such as dyslipidemia in patients with coronary artery disease is necessary. We aimed to evaluate the success rate of lipid control, during 9 months follow-up after percutaneous coronary intervention (PCI).
Patients and methods: A total of 195 patients (67.7% men, mean age = 57.8 ± 9.4 years) who underwent PCI in Tehran Heart Center were included. Serum lipid profiles were measured in all the patients before PCI and at 9-month follow-up. Dyslipidemia was defined as serum levels of LDL-C ≥ 100 or TG ≥ 150 or TC ≥ 200 or HDL-C ≤ 40 mg/dl in the men and ≤ 50 mg/dl or less in the women, or non-HDL-C ≥ 130 mg/dl with or without the consumption of lipid-lowering agents. During follow up, all patients were given atorvastatin 20-40 mg/day.
Results: Overall, 26.2% had diabetes mellitus, 42.6% had hypertension, and 34.9% were smokers. Dyslipidemia was more common in the women. At 9-month follow-up, there was no significant changes in terms of the prevalence of high HDL-C or low TG in patients; however, a significant increase was seen in the prevalence low TC in patients (63.6% vs. 80.5%; p value < 0.001), LDL-C (47.2% vs. 65.6%; p value < 0.001), and non-HDL-C (40.0% vs. 63.1%; p value < 0.001).
Conclusions: Although by current treatments, the prevalence of patients with low TC, LDL-C and non-HDL-C has significantly increased; dyslipidemia persisted in a considerable proportion of patients. These results necessitate further investigations into the relationship between high serum lipids and long-term outcome of patients after PCI as well as further evaluations of the dyslipidemia treatment strategies.
Keywords: Dyslipidemia; Lipid Control; Percutaneous Coronary Intervention.
Figures
Similar articles
-
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12. Endocrine. 2008. PMID: 19003544
-
Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.Clin Biochem. 2014 Sep;47(13-14):1239-44. doi: 10.1016/j.clinbiochem.2014.03.004. Epub 2014 Mar 21. Clin Biochem. 2014. PMID: 24657509
-
Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial.Curr Ther Res Clin Exp. 2004 Jul;65(4):330-44. doi: 10.1016/j.curtheres.2004.06.004. Curr Ther Res Clin Exp. 2004. PMID: 24672088 Free PMC article.
-
Pitavastatin: novel effects on lipid parameters.Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Atheroscler Suppl. 2011. PMID: 22152282 Review.
-
2017 Taiwan lipid guidelines for high risk patients.J Formos Med Assoc. 2017 Apr;116(4):217-248. doi: 10.1016/j.jfma.2016.11.013. Epub 2017 Feb 24. J Formos Med Assoc. 2017. PMID: 28242176 Review.
Cited by
-
Prevalence of Hypertension in Cardiovascular Disease in Iran: Systematic Review and Meta-Analysis.Int J Prev Med. 2020 Apr 30;11:56. doi: 10.4103/ijpvm.IJPVM_351_18. eCollection 2020. Int J Prev Med. 2020. PMID: 32577186 Free PMC article. Review.
-
Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.Lipids Health Dis. 2019 Feb 2;18(1):40. doi: 10.1186/s12944-019-0979-6. Lipids Health Dis. 2019. PMID: 30711009 Free PMC article.
-
Relationship Between Preprocedural Lipid Levels and Periprocedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.Tex Heart Inst J. 2022 Nov 1;49(6):e207384. doi: 10.14503/THIJ-20-7384. Tex Heart Inst J. 2022. PMID: 36515930 Free PMC article.
References
-
- Arsenault BJ, Rana JS, Stroes ES, Despres JP, Shah PK, Kastelein JJ, et al. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol. 2009;55(1):35–41. doi: 10.1016/j.jacc.2009.07.057. - DOI - PubMed
-
- Eyre H, Kahn R, Robertson RM, Clark NG, Doyle C, Hong Y, et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation. 2004;109(25):3244–55. doi: 10.1161/01.CIR.0000133321.00456.00. - DOI - PubMed
-
- Pres D, Gasior M, Lekston A, Gierlotka M, Hawranek M, Tajstra M, et al. Relationship between low-density lipoprotein cholesterol level on admission and in-hospital mortality in patients with ST-segment elevation myocardial infarction, with or without diabetes, treated with percutaneous coronary intervention. Kardiol Pol. 2010;68(9):1005–12. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous